Maxx Orthopedics was granted FDA 510(k) clearance to market the Freedom® Ultra-Congruent liner, part of the Freedom Knee® system.
The component is designed to achieve a higher level of constraint than is typically achieved with traditional cruciate-retaining knees. It features a deep anterior patellar cut-out to allow for tendon clearance, a prominent anterior lip to prevent anterior subluxation of the femur and a prominent posterior lip that resists posterior translation of the femur. Thicknesses vary in 1mm increments throughout the size range.
Source: Maxx Medical
Maxx Orthopedics was granted FDA 510(k) clearance to market the Freedom® Ultra-Congruent liner, part of the Freedom Knee® system.
The component is designed to achieve a higher level of constraint than is typically achieved with traditional cruciate-retaining knees. It features a deep anterior patellar cut-out to allow for tendon clearance, a...
Maxx Orthopedics was granted FDA 510(k) clearance to market the Freedom® Ultra-Congruent liner, part of the Freedom Knee® system.
The component is designed to achieve a higher level of constraint than is typically achieved with traditional cruciate-retaining knees. It features a deep anterior patellar cut-out to allow for tendon clearance, a prominent anterior lip to prevent anterior subluxation of the femur and a prominent posterior lip that resists posterior translation of the femur. Thicknesses vary in 1mm increments throughout the size range.
Source: Maxx Medical
You’ve reached your limit.
We’re glad you’re finding value in our content — and we’d love for you to keep going.
Subscribe now for unlimited access to orthopedic business intelligence.
JV
Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.





